Linjing Mu

3.0k total citations
106 papers, 2.2k citations indexed

About

Linjing Mu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Linjing Mu has authored 106 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 43 papers in Cellular and Molecular Neuroscience and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Linjing Mu's work include Neuroscience and Neuropharmacology Research (36 papers), Chemical Synthesis and Analysis (18 papers) and Cannabis and Cannabinoid Research (18 papers). Linjing Mu is often cited by papers focused on Neuroscience and Neuropharmacology Research (36 papers), Chemical Synthesis and Analysis (18 papers) and Cannabis and Cannabinoid Research (18 papers). Linjing Mu collaborates with scholars based in Switzerland, Germany and China. Linjing Mu's co-authors include Simon M. Ametamey, Roger Schibli, Stefanie D. Krämer, Adrienne Müller Herde, P. August Schubiger, Keith Graham, Ludger M. Dinkelborg, Timo Stellfeld, Claudia Keller and Ananth Srinivasan and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and NeuroImage.

In The Last Decade

Linjing Mu

101 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linjing Mu Switzerland 28 727 698 552 398 332 106 2.2k
Louisa Barré France 30 718 1.0× 940 1.3× 702 1.3× 459 1.2× 139 0.4× 128 3.4k
Françoise Hinnen France 26 1.1k 1.4× 718 1.0× 424 0.8× 353 0.9× 148 0.4× 66 2.2k
Katsushi Kumata Japan 25 748 1.0× 586 0.8× 524 0.9× 188 0.5× 125 0.4× 115 2.0k
Jan Passchier United Kingdom 28 775 1.1× 791 1.1× 488 0.9× 662 1.7× 137 0.4× 67 2.8k
Kazunori Kawamura Japan 32 1.6k 2.2× 739 1.1× 1.1k 2.0× 263 0.7× 301 0.9× 192 3.5k
Magnus Schou Sweden 23 398 0.5× 531 0.8× 429 0.8× 252 0.6× 145 0.4× 95 1.8k
Héric Valette France 27 1.0k 1.4× 949 1.4× 630 1.1× 274 0.7× 140 0.4× 107 2.7k
Qi-Huang Zheng United States 26 681 0.9× 484 0.7× 327 0.6× 354 0.9× 224 0.7× 93 1.9k
Tomoteru Yamasaki Japan 27 809 1.1× 592 0.8× 590 1.1× 149 0.4× 172 0.5× 117 2.1k
Chyng‐Yann Shiue United States 29 733 1.0× 1.3k 1.8× 1.0k 1.9× 246 0.6× 261 0.8× 114 3.4k

Countries citing papers authored by Linjing Mu

Since Specialization
Citations

This map shows the geographic impact of Linjing Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjing Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjing Mu more than expected).

Fields of papers citing papers by Linjing Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linjing Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjing Mu. The network helps show where Linjing Mu may publish in the future.

Co-authorship network of co-authors of Linjing Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Linjing Mu. A scholar is included among the top collaborators of Linjing Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linjing Mu. Linjing Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boccalini, Cecilia, Débora Elisa Peretti, Federica Ribaldi, et al.. (2025). Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment. European Journal of Nuclear Medicine and Molecular Imaging. 52(13). 5075–5084. 1 indexed citations
2.
Serdiuk, Tetiana, Dhiman Ghosh, Juan Gerez, et al.. (2025). Alpha-synuclein interacts with regulators of ATP homeostasis in mitochondria. Nature Communications. 16(1). 7651–7651.
3.
Albrecht, Manuela, et al.. (2025). Discovery of 1,3,4‐Oxadiazin‐5‐One Derivative CJ1‐34 as a Partial ATP Synthase Inhibitor for CNS Applications. Chemistry - A European Journal. 31(24). e202404517–e202404517. 1 indexed citations
4.
Haider, Ahmed, Susan Bengs, Angela Portmann, et al.. (2025). Age- and sex-specific differences in myocardial sympathetic tone and left ventricular remodeling following myocardial injury. Biology of Sex Differences. 16(1). 2–2.
5.
Williams, Richard D., et al.. (2024). Towards imaging the immune state of cancer by PET: Targeting legumain with 11C-labeled P1-Asn peptidomimetics carrying a cyano-warhead. Nuclear Medicine and Biology. 138-139. 108951–108951. 2 indexed citations
6.
Zheng, Ming‐Qiang, Jiwei Gu, Claudia Keller, et al.. (2024). Exploration of (R)-[11C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1556–1565. 1 indexed citations
7.
Keller, Claudia, Dominik Heer, Ludovic Collin, et al.. (2024). Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[11C]YH132: Application in Drug Development and Neurodegenerative Diseases. ChemBioChem. 25(7). e202300819–e202300819. 2 indexed citations
8.
Wang, Jinling, Roger Benoit, Xavier Deupí, et al.. (2024). Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2. European Journal of Nuclear Medicine and Molecular Imaging. 52(1). 9–21. 5 indexed citations
9.
Wang, Jie, Lin Huang, Junpeng Li, et al.. (2024). Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer’s disease: A [18F]PSS232 PET/MRI study. Alzheimer s Research & Therapy. 16(1). 9–9. 13 indexed citations
10.
Boccalini, Cecilia, Federica Ribaldi, Inès Hristovska, et al.. (2023). The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimer s & Dementia. 20(1). 221–233. 40 indexed citations
11.
12.
Krämer, Stefanie D., Uwe Grether, Matthias Wittwer, et al.. (2023). Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development. Journal of Nuclear Medicine. 65(2). 300–305. 1 indexed citations
13.
Ni, Ruiqing, Xosé Luís Deán‐Ben, Claudia Keller, et al.. (2023). Imaging increased metabolism in the spinal cord in mice after middle cerebral artery occlusion. Photoacoustics. 32. 100532–100532. 1 indexed citations
14.
Grether, Uwe, Jörg Benz, Dominik Heer, et al.. (2022). Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging. Journal of Medicinal Chemistry. 65(3). 2191–2207. 10 indexed citations
15.
Treyer, Valérie, et al.. (2021). Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease. Pharmaceuticals. 14(2). 110–110. 83 indexed citations
16.
Krämer, Stefanie D., Linjing Mu, Ahmed Haider, et al.. (2017). Evaluation of11C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk. Journal of Nuclear Medicine. 59(4). 698–703. 32 indexed citations
17.
Warnock, Geoffrey, Michael Sommerauer, Linjing Mu, et al.. (2017). A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 1041–1051. 16 indexed citations
18.
Honer, Michael, Linjing Mu, Timo Stellfeld, et al.. (2011). 18F-Labeled Bombesin Analog for Specific and Effective Targeting of Prostate Tumors Expressing Gastrin-Releasing Peptide Receptors. Journal of Nuclear Medicine. 52(2). 270–278. 55 indexed citations
19.
Mu, Linjing, et al.. (2010). Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands. Bioorganic & Medicinal Chemistry. 18(16). 6044–6054. 17 indexed citations
20.
Schneider, Richard, Hui Zhang, Linjing Mu, Amit S. Kalgutkar, & R. F. Bonner. (2010). Utility of multivariate analysis in support ofin vitrometabolite identification studies: retrospective analysis using the antidepressant drug nefazodone. Xenobiotica. 40(4). 262–274. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louisa Barré Breakdown of academic impact, for papers by Françoise Hinnen Breakdown of academic impact, for papers by Katsushi Kumata Breakdown of academic impact, for papers by Jan Passchier Breakdown of academic impact, for papers by Kazunori Kawamura Breakdown of academic impact, for papers by Magnus Schou Breakdown of academic impact, for papers by Héric Valette Breakdown of academic impact, for papers by Qi-Huang Zheng Breakdown of academic impact, for papers by Tomoteru Yamasaki Breakdown of academic impact, for papers by Chyng‐Yann Shiue
Rankless by CCL
2026